These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36997377)

  • 1. Corrigendum to "Functional connectivity differences in the amygdala are related to the antidepressant efficacy of ketamine in patients with anxious depression" [J. Affect. Disord. 320 (2023) 29-36].
    Yuan S; Luo X; Chen X; Wang M; Hu Y; Zhou Y; Ning Y; Zhang B
    J Affect Disord; 2023 Jun; 331():461. PubMed ID: 36997377
    [No Abstract]   [Full Text] [Related]  

  • 2. Functional connectivity differences in the amygdala are related to the antidepressant efficacy of ketamine in patients with anxious depression.
    Yuan S; Luo X; Chen X; Wang M; Hu Y; Zhou Y; Ning Y; Zhang B
    J Affect Disord; 2023 Jan; 320():29-36. PubMed ID: 36181911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional connectivity between the amygdala and subgenual cingulate gyrus predicts the antidepressant effects of ketamine in patients with treatment-resistant depression.
    Nakamura T; Tomita M; Horikawa N; Ishibashi M; Uematsu K; Hiraki T; Abe T; Uchimura N
    Neuropsychopharmacol Rep; 2021 Jun; 41(2):168-178. PubMed ID: 33615749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum to "Altered centromedial amygdala functional connectivity in adults is associated with childhood emotional abuse and predicts levels of depression and anxiety" [J. Affect. Disord. 303 (2022) 148-154].
    Luo L; Yang T; Zheng X; Zhang X; Gao S; Li Y; Stamatakis EA; Sahakian B; Becker B; Lin Q; Kendrick KM
    J Affect Disord; 2023 Dec; 343():166. PubMed ID: 37778928
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to Antisuicidal Effect, BDNF Val66Met Polymorphism, and Low-Dose Ketamine Infusion: Reanalysis of Adjunctive Ketamine Study of Taiwanese Patients with Treatment-Resistant Depression (AKSTP-TRD). J Affect Disord. 2019 May 15;251:162-169. doi: 10.1016/j.jad.2019.03.075. Epub 2019 Mar 23.
    Chen MH; Lin WC; Wu HJ; Cheng CM; Li CT; Hong CJ; Tu PC; Bai YM; Tsai SJ; Su TP
    J Affect Disord; 2020 Sep; 274():1217. PubMed ID: 32663955
    [No Abstract]   [Full Text] [Related]  

  • 6. Functional connectivity of the amygdala and the antidepressant and antisuicidal effects of repeated ketamine infusions in major depressive disorder.
    Liu H; Wang C; Lan X; Li W; Zhang F; Fu L; Ye Y; Ning Y; Zhou Y
    Front Neurosci; 2023; 17():1123797. PubMed ID: 36816116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anterior cingulate desynchronization and functional connectivity with the amygdala during a working memory task predict rapid antidepressant response to ketamine.
    Salvadore G; Cornwell BR; Sambataro F; Latov D; Colon-Rosario V; Carver F; Holroyd T; DiazGranados N; Machado-Vieira R; Grillon C; Drevets WC; Zarate CA
    Neuropsychopharmacology; 2010 Jun; 35(7):1415-22. PubMed ID: 20393460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single infusion of ketamine improves depression scores in patients with anxious bipolar depression.
    Ionescu DF; Luckenbaugh DA; Niciu MJ; Richards EM; Zarate CA
    Bipolar Disord; 2015 Jun; 17(4):438-43. PubMed ID: 25400146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corrigendum to "Cognitive function of patients with treatment-resistant depression after a single low dose of ketamine infusion". J Affect Disord. 2018 Dec 1;241:1-7. doi: 10.1016/j.jad.2018.07.033. Epub 2018 Jul 27.
    Chen MH; Lin WC; Wu HJ; Cheng CM; Li CT; Hong CJ; Tu PC; Bai YM; Tsai SJ; Su TP
    J Affect Disord; 2020 Sep; 274():1219. PubMed ID: 32663957
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to "Continuation phase intravenous ketamine in adults with treatment-resistant depression" [J. Affect. Disord. 206 (2016) 300-304].
    Vande Voort JL; Morgan RJ; Kung S; Rasmussen KG; Rico J; Palmer BA; Schak KM; Tye SJ; Ritter MJ; Frye MA; Bobo WV
    J Affect Disord; 2018 Aug; 236():313. PubMed ID: 28967437
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of Serial Ketamine Infusions on Corticolimbic Functional Connectivity in Major Depression.
    Vasavada MM; Loureiro J; Kubicki A; Sahib A; Wade B; Hellemann G; Espinoza RT; Congdon E; Narr KL; Leaver AM
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jul; 6(7):735-744. PubMed ID: 32900657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain functional abnormalities in the amygdala subregions is associated with anxious depression.
    Qiao J; Tao S; Wang X; Shi J; Chen Y; Tian S; Yao Z; Lu Q
    J Affect Disord; 2020 Nov; 276():653-659. PubMed ID: 32871697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine.
    Ionescu DF; Luckenbaugh DA; Niciu MJ; Richards EM; Slonena EE; Vande Voort JL; Brutsche NE; Zarate CA
    J Clin Psychiatry; 2014 Sep; 75(9):e932-8. PubMed ID: 25295436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between depression subtypes and response to repeated-dose intravenous ketamine.
    Wang C; Zhou Y; Zheng W; Liu W; Zhan Y; Li H; Chen L; Zhang B; Walter M; Li M; Li MD; Ning Y
    Acta Psychiatr Scand; 2019 Nov; 140(5):446-457. PubMed ID: 31483855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged ketamine infusion modulates limbic connectivity and induces sustained remission of treatment-resistant depression.
    Siegel JS; Palanca BJA; Ances BM; Kharasch ED; Schweiger JA; Yingling MD; Snyder AZ; Nicol GE; Lenze EJ; Farber NB
    Psychopharmacology (Berl); 2021 Apr; 238(4):1157-1169. PubMed ID: 33483802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of low-dose ketamine on the prefrontal cortex and amygdala in treatment-resistant depression: A randomized controlled study.
    Li CT; Chen MH; Lin WC; Hong CJ; Yang BH; Liu RS; Tu PC; Su TP
    Hum Brain Mapp; 2016 Mar; 37(3):1080-90. PubMed ID: 26821769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of low-dose ketamine infusion in anxious vs nonanxious depression: revisiting the Adjunctive Ketamine Study of Taiwanese Patients with Treatment-Resistant Depression.
    Chen MH; Lin WC; Wu HJ; Bai YM; Li CT; Tsai SJ; Hong CJ; Tu PC; Cheng CM; Su TP
    CNS Spectr; 2021 Aug; 26(4):362-367. PubMed ID: 32419678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketamine decreases resting state functional network connectivity in healthy subjects: implications for antidepressant drug action.
    Scheidegger M; Walter M; Lehmann M; Metzger C; Grimm S; Boeker H; Boesiger P; Henning A; Seifritz E
    PLoS One; 2012; 7(9):e44799. PubMed ID: 23049758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary differences in resting state MEG functional connectivity pre- and post-ketamine in major depressive disorder.
    Nugent AC; Robinson SE; Coppola R; Zarate CA
    Psychiatry Res Neuroimaging; 2016 Aug; 254():56-66. PubMed ID: 27362845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional connectivity of the prefrontal cortex and amygdala is related to depression status in major depressive disorder.
    Zhang A; Yang C; Li G; Wang Y; Liu P; Liu Z; Sun N; Zhang K
    J Affect Disord; 2020 Sep; 274():897-902. PubMed ID: 32664030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.